IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
100.18
+1.46 (1.48%)
At close: Mar 9, 2026, 4:00 PM EDT
100.18
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

IRADIMED CORPORATION Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
21.1819.2317.1912.839.331.37
Depreciation & Amortization
0.980.820.770.671.411.34
Stock-Based Compensation
2.882.522.191.391.463.96
Other Adjustments
0.15-0.7-0.770.210.640.32
Change in Receivables
-3.411.760.84-8.24-0.582.69
Changes in Inventories
0.423.13-7.47-1.31-0.39-0.28
Changes in Accounts Payable
0.05-0.86-0.221.120.03-0.4
Changes in Accrued Expenses
0.791-0.10.061.1-0.45
Changes in Income Taxes Payable
-1.47-0.790.253.05-0.83-1.11
Changes in Unearned Revenue
1.43-0.110.620.530.05-0.01
Changes in Other Operating Activities
-0.38-0.380.16-0.27-0.96-1.61
Operating Cash Flow
25.0125.6213.4710.0411.265.82
Operating Cash Flow Growth
6.21%90.30%34.08%-10.80%93.52%-43.15%
Capital Expenditures
-10.26-8.01-7.44-0.82-0.48-0.44
Purchases of Intangible Assets
-0.8-0.81-0.57-1.05-0.26-0.19
Proceeds from Sale of Investments
---0.51.390.88
Investing Cash Flow
-11.06-8.82-8.01-1.370.650.25
Issuance of Common Stock
0.030.030.180.150.621.73
Repurchase of Common Stock
-0.78-0.69-0.61-0.29-0.6-1.21
Net Common Stock Issued (Repurchased)
-0.76-0.66-0.43-0.150.020.52
Common Dividends Paid
-8.39-13.68-13.22-12.56--
Financing Cash Flow
-9.15-14.34-13.66-12.710.020.52
Net Cash Flow
4.812.47-8.2-4.0411.936.59
Free Cash Flow
14.7517.626.029.2210.785.37
Free Cash Flow Growth
-16.28%192.46%-34.66%-14.44%100.50%-45.52%
FCF Margin
18.32%24.06%9.19%17.30%25.77%16.94%
Free Cash Flow Per Share
1.151.380.470.730.860.43
Levered Free Cash Flow
12.9114.033.7715.869.25-1.6
Unlevered Free Cash Flow
11.2912.22.4215.429.23-1.29
Updated Nov 3, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q